Sponsor Pipeline

Zhejiang Haichang Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06309485 Phase 2 Study of WGI-0301 for Advanced HCC Advanced Hepatocellular Carcinoma (HCC) Recruiting
NCT07494435 Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC Hepato Cellular Carcinoma (HCC) Not Yet Recruiting
Phase 1/2
NCT07540832 Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC Advanced Hepatocellular Carcinoma (HCC) Not Yet Recruiting
Disease Areas
Liver Cancer (3)
Get alerts when Zhejiang Haichang Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free